Treatment Outcomes With Novel Targeted and Immunotherapeutic Regimens in CAYA Hodgkin Lymphoma: A Retrospective Study

Documenti analoghi

• Metronomic Chemotherapy in Breast Cancer: Unleashing the Potential of Combination Regimens
  di: Jiaxuan Liu, et al.
  Pubblicazione: (2025)
• Binary and Ternary Classification Prediction for Breast Cancer and Breast Sclerosing Adenosis With Interpretable Artificial Intelligence From Clinical and Imaging Features: A Retrospective, Diagnostic Accuracy Cohort Study
  di: Yang Qu, et al.
  Pubblicazione: (2026)
• A Novel Sensitive Technique to Detect ESR1 Hotspot Mutations in Liquid Biopsy Using Switch‐Blocker–Enhanced Targeted Amplification Coupled With Pyrosequencing
  di: Yantong Zhou, et al.
  Pubblicazione: (2026)
• Combining Small‐Molecular Compounds With CAR T‐Cell Therapy: Novel Strategies for Enhanced Cancer Immunotherapy
  di: Rangzi Yi, et al.
  Pubblicazione: (2026)
• Inetetamab combined with sirolimus and chemotherapy for the treatment of HER2‐positive metastatic breast cancer patients with abnormal activation of the PI3K/Akt/mTOR pathway after trastuzumab treatment
  di: Qiao Li, et al.
  Pubblicazione: (2024)